🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementSkin rash at injection site — allergy vs preservative sensitivity Page 3

Skin rash at injection site — allergy vs preservative sensitivity

Dr.DermMIA Fri, May 15, 2026 at 1:23 AM 13 replies 684 viewsPage 3 of 3
SteveThurs
Member
523
2,345
Sep 2024
Wisconsin
Online
May 17, 2026 at 1:09 AM#11
KevinCompounds said:
I see both sides of injection-site reactions in my clinical practice.

Bookmarking. The distinction being drawn above is the one nobody else makes.

Last edited: May 17, 2026 at 5:09 AM
38 11MaxMetOK, MounjBrad, nick_newbie and 35 others
Reply Quote Save Share Report
chris_chi24
Member
389
1,678
Sep 2024
Chicago, IL
May 17, 2026 at 5:49 AM#12

From the other side of the consultation, briefly. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

39 12MounjBrad, nick_newbie, DadBodDave and 36 others
Reply Quote Save Share Report
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
May 17, 2026 at 10:28 AM#13
PharmacoVig_BOS said:
Has anyone on injection-site reactions tried splitting their dose across two injection sites?

This is where I part company with the consensus forming above. This treats a plausible mechanism as a demonstrated one. Plausible is where you start looking, not where you stop.

Last edited: May 17, 2026 at 2:28 PM
40 13FDA_TrackerJim, ricardo_MIA, BrianDallas92 and 37 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
raj_cambridge
Member
489
2,123
Jun 2024
Cambridge, MA
May 17, 2026 at 3:07 PM#14

Adding the numbers, since they settle part of this. Practical: whatever you change, write down the date and the reason. In three months the reason is what you will have forgotten, and the reason is what makes the record worth having.

Last edited: May 17, 2026 at 4:07 PM
41 14PharmHunterJen, TomTeleRx, DoseLogDan and 38 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
May 17, 2026 at 7:46 PM#15

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source. Tagging this one for the weekly digest.

42 15PurityPaulOR, MaxMetOK, MounjBrad and 39 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register